Stockscreener 앱 받기
3.25
1.22%
-0.04
Mural Oncology Plc 주식(MURA)의 최신 뉴스
Mural Oncology to Host First Virtual Investor Day on September 26, 2024 - ForexTV.com
Mural Oncology to Host First Virtual Investor Day on September 26, 2024 - EIN News
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
MURAMural Oncology plc Ordinary Shares Latest Stock News & Market Updates - StockTitan
Mural Oncology to Present at Two Upcoming Investor Conferences - ForexTV.com
Mural Oncology to Present at Two Upcoming Investor Conferences - StockTitan
Mural Oncology plc (NASDAQ:MURA) Sees Significant Decrease in Short Interest - MarketBeat
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress - BioSpace
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress - wallstreet:online
Harbor Capital Advisors Inc. Takes Position in Mural Oncology plc (NASDAQ:MURA) - Defense World
Critical Analysis: Mural Oncology (NASDAQ:MURA) & Kamada (NASDAQ:KMDA) - Defense World
Mural Oncology Appoints George Golumbeski, Ph.D., to its Board of Directors - citybiz
Mural Oncology appoints new independent director By Investing.com - Investing.com Nigeria
Mural Oncology appoints George Golumbeski to board - Investing.com
Mural Oncology appoints new independent director - Investing.com India
Mural Oncology appoints new independent director - Investing.com
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors - ForexTV.com
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors - StockTitan
Head to Head Survey: Mural Oncology (NASDAQ:MURA) and Mereo BioPharma Group (NASDAQ:MREO) - Defense World
Mural Oncology plc (NASDAQ:MURA) Short Interest Down 18.4% in June - Defense World
Short Interest in Mural Oncology plc (NASDAQ:MURA) Declines By 18.4% - MarketBeat
Evaluating MURA’s financial ratios for a profitable investment - US Post News
Mural Oncology plc (NASDAQ:MURA) CEO Caroline Loew Sells 12,531 Shares of Stock - Defense World
Mural Oncology plc (NASDAQ:MURA) CEO Caroline Loew Sells 12,531 Shares - MarketBeat
Mural Oncology reports inducement grants under Nasdaq listing rule - Medical Buyer
Nothing is Better Than Mural Oncology plc (MURA) stock at the moment - SETE News
Rodman & Renshaw Begins Coverage on Mural Oncology (NASDAQ:MURA) - MarketBeat
Mural Oncology (NASDAQ:MURA) Trading Up 0.3% - MarketBeat
Mural Oncology (NASDAQ:MURA) Trading 0.3% Higher - Defense World
Views of Wall Street's Leading Experts on Mural Oncology plc – Sete News - SETE News
Mural to Present and Host 1×1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference - ForexTV.com
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference - GlobeNewswire Inc.
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
Mural Oncology plc (NASDAQ:MURA) Sees Significant Decline in Short Interest - MarketBeat
Closing Figures: Mural Oncology plc (MURA)'s Negative Finish at 3.35, Down -6.42 – DWinneX - The Dwinnex
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting - ForexTV.com
Mural Oncology (NASDAQ:MURA) Stock Price Down 3.3% - Defense World
Cavendish Financial (LON:CAV) Stock Price Up 8.7% - Defense World
Seven new option listings on May 15thTipRanks.com - TipRanks
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update14.05.2024 - wallstreet:online
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update - Investing.com India
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Investing.com India
Mural Oncology (NASDAQ:MURA) Stock Price Down 1.9% - Defense World
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewswire Inc.
Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition? - Yahoo Finance
Mural Oncology Primed For IL-2 Readouts Next Year - Scrip
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting - GlobeNewswire Inc.
Alkermes plc: Collecting The Fruits Of The 2023 Spinoff - Seeking Alpha
We're Keeping An Eye On Mural Oncology's (NASDAQ:MURA) Cash Burn Rate - Simply Wall St
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update - GlobeNewswire Inc.
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development - Yahoo Finance
Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value (NASDAQ:MURA) - Seeking Alpha
The 3 Most Undervalued Biotech Stocks to Buy in January - Yahoo Finance
JPM24: After 'clearing the decks,' Alkermes ready to roll as pure-play neuroscience company - FiercePharma
Arthur Cox Tax Group Update December 2023 - Arthur Cox
Novo Nordisk acquires Alkermes’s Irish plant to expand manufacturing capacity - Pharmaceutical Technology
ALKS: 3 A-Rated Biotech Stocks for Your 2024 Portfolio - StockNews.com
Arthur Cox guides Alkermes in oncology business separation - ICLG.com
Arthur Cox advises Alkermes plc on separation of its oncology business - Arthur Cox
Mural Oncology (NASDAQ:MURA) Stock Quotes, Forecast and News Summary - Benzinga
Why Is Mural Oncology (MURA) Stock Up 59% Today? - InvestorPlace
Mural Oncology spins out from Alkermes with $275M, lead immunotherapy program - MM+M Online
MURAMural Oncology plc Latest Stock News & Market Updates - StockTitan
Alkermes separates cancer drug business as new company Mural - BioPharma Dive
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement - PR Newswire
Alkermes plc Reports Third Quarter 2023 Financial Results - PR Newswire
Alkermes plc Reports Second Quarter 2023 Financial Results - PR Newswire
Stunning Christy Dignam mural pops up in Dublin after sad death from cancer - Irish Mirror
Alkermes To Spin-Off Mural Oncology In 2H23 - Forbes
1.26%
1.94%
자본화:
|
볼륨(24시간):